Results 161 to 170 of about 34,537 (182)

Tenofovir

Reactions Weekly, 2003
openaire   +1 more source

Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide

Journal of Antimicrobial Chemotherapy, 2019
Marta Boffito, Anton Pozniak, Charles Flexner   +2 more
exaly  

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Daniel Podzamczer, Paul Edward Sax, Scott Mccallister   +2 more
exaly  

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

Clinical Infectious Diseases, 2015
Heidi Kalkwarf, Julia Wei Wu, Lynne Mofenson   +2 more
exaly  

Tenofovir

Reactions Weekly, 2012
openaire   +1 more source

Tenofovir

Reactions Weekly, 2015
openaire   +2 more sources

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AIDS Patient Care and STDs, 2019
Pia Kivelä, Jussi Sutinen
exaly  

Tenofovir

Reactions Weekly, 2014
  +4 more sources

Tenofovir Alafenamide

Annals of Pharmacotherapy, 2016

exaly  

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide

EBioMedicine, 2016
Scott Mccallister, Manjusha Kulkarni, Andrew Cheng   +2 more
exaly